Literature DB >> 21605498

Evaluation of oxidative stress status in children with pervasive developmental disorder and attention deficit hyperactivity disorder using urinary-specific biomarkers.

Masao Kawatani, Hirokazu Tsukahara, Mitsufumi Mayumi.   

Abstract

Pervasive developmental disorder (PDD) and attention deficit hyperactivity disorder (ADHD) are likely to be associated with increased oxidative stress, particularly that of lipid peroxidation. We evaluated the oxidative stress status of pediatric PDD and ADHD patients using their urine samples. Urinary acrolein-lysine levels in 11 PDD and 10 ADHD children (205 ± 97 and 234 ± 75 nmol/mg Cr, respectively) appeared higher than those of the control subjects (155 ± 59 nmol/mg Cr). Measurement of urinary specific biomarkers is comfortable, non-invasive, and easy to perform in children. Our findings might provide a scientific guide for use in further clinical and biochemical studies of these disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605498      PMCID: PMC6837692          DOI: 10.1179/174329211X12968219310873

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  4 in total

1.  Increased excretion of a lipid peroxidation biomarker in autism.

Authors:  X Ming; T P Stein; M Brimacombe; W G Johnson; G H Lambert; G C Wagner
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2005-11       Impact factor: 4.006

Review 2.  Biomarkers for oxidative stress: clinical application in pediatric medicine.

Authors:  Hirokazu Tsukahara
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

3.  Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins.

Authors:  Abha Chauhan; Ved Chauhan; W Ted Brown; Ira Cohen
Journal:  Life Sci       Date:  2004-10-08       Impact factor: 5.037

4.  Malondialdehyde levels in adult attention-deficit hyperactivity disorder.

Authors:  Mahmut Bulut; Salih Selek; H Serdar Gergerlioglu; Haluk A Savas; H Ramazan Yilmaz; Murat Yuce; Giyasettin Ekici
Journal:  J Psychiatry Neurosci       Date:  2007-11       Impact factor: 6.186

  4 in total
  11 in total

1.  Serum Heat Shock Protein 70 Level in Children with Attention Deficiency Hyperactivity Disorder.

Authors:  Ahmet Özaslan; Esra Güney; Özlem Gülbahar; Dicle Büyüktaşkin Tunçtürk; Burak Arslan; Güner Melike Güveli Bozkurt
Journal:  Noro Psikiyatr Ars       Date:  2022-02-06       Impact factor: 1.339

2.  Effect of vitamin D supplementation on brain waves, behavioral performance, nitric oxide, malondialdehyde, and high-sensitivity C-reactive protein in children with attention deficit/hyperactivity disorder: study protocol for a randomized clinical trial.

Authors:  Abbas Ali Sangouni; Hamid Mirhosseini; Mahdieh Hosseinzadeh
Journal:  Trials       Date:  2022-10-22       Impact factor: 2.728

3.  Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison.

Authors:  Annelies A J Verlaet; Annelies Breynaert; Berten Ceulemans; Tess De Bruyne; Erik Fransen; Luc Pieters; Huub F J Savelkoul; Nina Hermans
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-10-22       Impact factor: 4.785

4.  Increased oxidative stress in children with attention deficit hyperactivity disorder.

Authors:  Hatice Sezen; Hasan Kandemir; Emin Savik; Sultan Basmacı Kandemir; Fethiye Kilicaslan; Hasan Bilinc; Nurten Aksoy
Journal:  Redox Rep       Date:  2016-02-18       Impact factor: 4.412

5.  Superoxide free radical spin-lattice relaxivity: A quench-assisted MR study.

Authors:  Martin J MacKinnon; Bruce A Berkowitz; Yen-Yu Ian Shih
Journal:  Magn Reson Med       Date:  2021-03-23       Impact factor: 3.737

Review 6.  Lipid peroxidation in psychiatric illness: overview of clinical evidence.

Authors:  Yash B Joshi; Domenico Praticò
Journal:  Oxid Med Cell Longev       Date:  2014-04-27       Impact factor: 6.543

7.  Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial.

Authors:  Annelies A J Verlaet; Berten Ceulemans; Helene Verhelst; Dirk Van West; Tess De Bruyne; Luc Pieters; Huub F J Savelkoul; Nina Hermans
Journal:  Trials       Date:  2017-03-28       Impact factor: 2.279

Review 8.  Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications.

Authors:  Ana Checa-Ros; Antonio Jeréz-Calero; Antonio Molina-Carballo; Cristina Campoy; Antonio Muñoz-Hoyos
Journal:  Nutrients       Date:  2021-01-16       Impact factor: 5.717

9.  Exposome of attention deficit hyperactivity disorder in Taiwanese children: exploring risks of endocrine-disrupting chemicals.

Authors:  Alexander Waits; Chia-Huang Chang; Ching-Jung Yu; Jung-Chieh Du; Hsien-Chih Chiou; Jia-Woei Hou; Winnie Yang; Hsin-Chang Chen; Ying-Sheue Chen; Betau Hwang; Mei-Lien Chen
Journal:  J Expo Sci Environ Epidemiol       Date:  2021-07-15       Impact factor: 5.563

Review 10.  Rationale for Dietary Antioxidant Treatment of ADHD.

Authors:  Annelies A J Verlaet; Carlijn M Maasakkers; Nina Hermans; Huub F J Savelkoul
Journal:  Nutrients       Date:  2018-03-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.